News, trends & global reports for pharma and biotech manufacturers, suppliers & scientists - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

News
The top business, scientific and regulatory news from the pharmaceutical and biotechnology industries.

NIH Launches Human Safety Study of Ebola Vaccine Candidate

August 29, 2014

The National Institute of Allergy and Infectious Diseases will begin the first in a series of trials for an Ebola vaccine during the week of Sept. 1.

Innova BioSciences Introduces InnovaGOLD Nanoparticles

August 28, 2014

New ultra-high quality gold nanoparticles simplify assay development and improve the sensitivity of immunoassays.

CPhI Worldwide to Host Tweetchat #CPhIChat on Key Issues Facing the Pharma Industry

August 28, 2014

CPhI Worldwide is launching #CPhIChat, a global industry-wide Tweetchat aimed to facilitate conversations on key issues facing the pharmaceutical industry.

DPx Holdings Acquires Gallus BioPharmaceuticals

August 27, 2014

DPx Holdings reaches definitive agreement to acquire all shares of Gallus biopharmaceuticals.

USP Joins in the Efforts to Stop Illegal Online Drug Sales

August 26, 2014

The US Pharmacopeial Convention joins with the Alliance for Safe Online Pharmacies to lower the number of illegal medicines sold online.

ViiV Healthcare receives FDA approval for HIV treatment

August 26, 2014

FDA approves new single-pill regimen for treatment of HIV-1 infection.

Ebola Vaccine Using DepoVax Shows Positive Results

August 26, 2014

Immunovaccine's DepoVax Ebola vaccine proves highly efficacious in non-human primate study.

Roche to Acquire InterMune for $8.3 billion

August 24, 2014

Roche's acquisition of InterMune and its lead product pirfenidone for idiopathic pulmonary fibrosis will expand Roche's respiratory product portfolio.

Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen

August 20, 2014

The companies will conduct clinical trials to evaluate a combination immune checkpoint inhibitor and a chemotherapy.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here